Acne Phage Serum

Description

Acne Phase Serum is a topical formulation designed for the management of acne. It is specifically formulated to target acne lesions and reduce inflammation. The serum is presented in a clear, viscous liquid form, suitable for application on the skin. The active ingredients work synergistically to promote skin clarity and improve overall complexion. The product is intended for use as part of a comprehensive acne treatment regimen.

Uses and Indications

This drug is indicated for the treatment of acne. It helps to clear up acne blemishes and allows the skin to heal effectively.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of the product. The product should be applied as a thin layer to cover the entire affected area.

Initial treatment should begin with one application daily. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two to three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

The use of this product is contraindicated in patients who are concurrently using another topical acne medication. The combination may increase the risk of skin irritation and dryness. If irritation occurs, discontinue use and limit to one topical acne medication at a time.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients against the concurrent use of this product with other topical acne medications. If irritation develops, it is recommended to discontinue use of all topical acne treatments and to limit application to one topical acne medication at a time to mitigate the risk of exacerbating skin irritation.

In cases where irritation occurs, patients should be instructed to cease use and consult a healthcare provider for further evaluation and management. Regular monitoring of the skin's response to treatment is advised to ensure safety and efficacy.

Side Effects

For external use only. Patients should discontinue use if irritation occurs.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use to one topical acne medication at a time to mitigate these effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Phage Serum (encapsulated salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of Acne Phage Serum (encapsulated salicylic acid cream) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and discuss potential risks and benefits with their patients. Given the lack of data, it is advisable to avoid use unless the potential benefits outweigh any potential risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. It is important to monitor renal function tests regularly in patients with known kidney problems. Additionally, a reduced dose should be considered for patients with a creatinine clearance of less than 30 mL/min.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the context of overdosage, there is currently no specific information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse reactions that may arise.

In the absence of detailed overdosage data, it is recommended that standard supportive measures be employed. This includes ensuring the patient's safety, providing symptomatic treatment, and considering the use of activated charcoal if the ingestion occurred within a timeframe that warrants its use.

Healthcare providers should remain vigilant and report any observed adverse effects to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed about the potential for skin irritation and dryness when using this product, particularly if they are concurrently using another topical acne medication. It is important to counsel patients to monitor their skin condition closely. If irritation occurs, they should discontinue the use of one of the topical acne medications to minimize adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from high temperatures. Additionally, the product must be protected from freezing conditions. Care should be taken to keep the product away from flame, fire, and heat sources to maintain its integrity and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Acne Phage Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)